Margaret A. Park

2.7k total citations
55 papers, 2.1k citations indexed

About

Margaret A. Park is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Margaret A. Park has authored 55 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Margaret A. Park's work include Autophagy in Disease and Therapy (11 papers), Endoplasmic Reticulum Stress and Disease (10 papers) and Cell death mechanisms and regulation (9 papers). Margaret A. Park is often cited by papers focused on Autophagy in Disease and Therapy (11 papers), Endoplasmic Reticulum Stress and Disease (10 papers) and Cell death mechanisms and regulation (9 papers). Margaret A. Park collaborates with scholars based in United States, Russia and Canada. Margaret A. Park's co-authors include Paul Dent, Steven Grant, Adly Yacoub, Paul B. Fisher, Clint Mitchell, Mohamed Rahmani, Hossein A. Hamed, David T. Curiel, Charles E. Chalfant and Guo Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Margaret A. Park

53 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Margaret A. Park United States	28	1.4k	574	513	311	310	55	2.1k
Clint Mitchell United States	30	1.6k 1.2×	846 1.5×	528 1.0×	347 1.1×	245 0.8×	43	2.5k
Christina Voelkel‐Johnson United States	34	2.0k 1.5×	595 1.0×	303 0.6×	411 1.3×	300 1.0×	81	2.8k
Xianling Guo China	22	950 0.7×	492 0.9×	609 1.2×	143 0.5×	92 0.3×	47	1.7k
Keren Paz United States	21	1.7k 1.2×	560 1.0×	233 0.5×	701 2.3×	112 0.4×	33	2.6k
Sylvia Wilder Israel	15	1.9k 1.3×	1.0k 1.8×	313 0.6×	492 1.6×	144 0.5×	21	2.7k
Hui‐Ming Chang United States	21	1.0k 0.7×	362 0.6×	331 0.6×	144 0.5×	115 0.4×	49	2.1k
Diane Crighton United Kingdom	17	1.3k 1.0×	581 1.0×	935 1.8×	397 1.3×	73 0.2×	24	2.1k
Steven Grant United States	24	1.2k 0.9×	794 1.4×	167 0.3×	258 0.8×	505 1.6×	35	2.1k
Antonio F. Santidrián Spain	21	1.2k 0.8×	429 0.7×	274 0.5×	77 0.2×	108 0.3×	30	1.8k
Abdul Qader Sukkurwala France	14	883 0.6×	932 1.6×	668 1.3×	223 0.7×	129 0.4×	17	2.6k

Countries citing papers authored by Margaret A. Park

Since Specialization

Citations

This map shows the geographic impact of Margaret A. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret A. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret A. Park more than expected).

Fields of papers citing papers by Margaret A. Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret A. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret A. Park. The network helps show where Margaret A. Park may publish in the future.

Co-authorship network of co-authors of Margaret A. Park

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret A. Park. A scholar is included among the top collaborators of Margaret A. Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret A. Park. Margaret A. Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chaput, Dale, et al.. (2023). CCAR-1 works together with the U2AF large subunit UAF-1 to regulate alternative splicing. RNA Biology. 21(1). 102–112.

Park, Margaret A., et al.. (2023). Deregulated expression of the 14q32 miRNA cluster in clear cell renal cancer cells. Frontiers in Oncology. 13. 1048419–1048419. 2 indexed citations

Vu, Ngoc, Margaret A. Park, Michael D. Shultz, et al.. (2016). Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung Tumorigenesis. Cancer Research. 76(10). 2977–2989. 14 indexed citations

Vu, Ngoc, et al.. (2015). The Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2 Drives Anoikis Resistance and the Metastasis of Triple Negative Breast Cancer. Journal of Biological Chemistry. 290(42). 25717–25727. 29 indexed citations

Hamed, Hossein A., Adly Yacoub, Margaret A. Park, et al.. (2013). Histone Deacetylase Inhibitors Interact with Melanoma Differentiation Associated-7/Interleukin-24 to Kill Primary Human Glioblastoma Cells. Molecular Pharmacology. 84(2). 171–181. 20 indexed citations

Chalfant, Charles E., et al.. (2013). OSU-03012 sensitizes breast cancers to lapatinib-induced cell killing: a role for Nck1 but not Nck2. BMC Cancer. 13(1). 256–256. 14 indexed citations

Shultz, Jacqueline C., Rachel W. Goehe, Dayanjan S. Wijesinghe, et al.. (2011). SRSF1 Regulates the Alternative Splicing of Caspase 9 Via A Novel Intronic Splicing Enhancer Affecting the Chemotherapeutic Sensitivity of Non–Small Cell Lung Cancer Cells. Molecular Cancer Research. 9(7). 889–900. 73 indexed citations

Park, Margaret A., Adly Yacoub, Hossein A. Hamed, et al.. (2011). Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells. Cancer Research. 71(14). 4955–4967. 97 indexed citations

Walker, Teneille, Clint Mitchell, Margaret A. Park, et al.. (2010). 17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca2+-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species. Molecular Cancer Therapeutics. 9(5). 1378–1395. 16 indexed citations

10.

Park, Margaret A., Clint Mitchell, Guo Zhang, et al.. (2010). Vorinostat and Sorafenib Increase CD95 Activation in Gastrointestinal Tumor Cells through a Ca2+- De novo Ceramide-PP2A-Reactive Oxygen Species–Dependent Signaling Pathway. Cancer Research. 70(15). 6313–6324. 86 indexed citations

11.

Park, Margaret A., Roland Reinehr, Dieter Häussinger, et al.. (2010). Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells. Molecular Cancer Therapeutics. 9(8). 2220–2231. 74 indexed citations

12.

Das, Anindita, David Durrant, Clint Mitchell, et al.. (2010). Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction. Proceedings of the National Academy of Sciences. 107(42). 18202–18207. 137 indexed citations

13.

Dent, Paul, Margaret A. Park, Rupesh Dash, et al.. (2010). The development of MDA-7/IL-24 as a cancer therapeutic. Pharmacology & Therapeutics. 128(2). 375–384. 50 indexed citations

14.

Dash, Rupesh, Sujit K. Bhutia, Belal Azab, et al.. (2010). mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity. Cytokine & Growth Factor Reviews. 21(5). 381–391. 91 indexed citations

15.

Hamed, Hossein A., Adly Yacoub, Margaret A. Park, et al.. (2010). OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins. Cancer Biology & Therapy. 9(7). 526–536. 37 indexed citations

16.

Park, Margaret A., Teneille Walker, Aditi Pandya Martin, et al.. (2009). MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK–dependent mechanism. Molecular Cancer Therapeutics. 8(5). 1280–1291. 40 indexed citations

17.

Martin, Aditi Pandya, Margaret A. Park, Clint Mitchell, et al.. (2009). BCL-2 Family Inhibitors Enhance Histone Deacetylase Inhibitor and Sorafenib Lethality via Autophagy and Overcome Blockade of the Extrinsic Pathway to Facilitate Killing. Molecular Pharmacology. 76(2). 327–341. 72 indexed citations

18.

Park, Margaret A., Guo Zhang, Clint Mitchell, et al.. (2008). Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95. Molecular Cancer Therapeutics. 7(9). 2633–2648. 41 indexed citations

19.

Zhang, Guo, Margaret A. Park, Clint Mitchell, et al.. (2008). Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation. Clinical Cancer Research. 14(17). 5385–5399. 101 indexed citations

20.

Yacoub, Adly, Margaret A. Park, Pankaj Gupta, et al.. (2008). Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells. Molecular Cancer Therapeutics. 7(2). 297–313. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact